Faeth Therapeutics FTH
NASDAQ FTH
$21.08 +0.29 (+1.39%)
As of: Oct 21, 2026 · 11:41 AM EDT

Faeth Therapeutics (FTH) Preferred Stock Liabilities (2020)

Updated

Faeth Therapeutics (FTH) recorded Preferred Stock Liabilities of $72.34 million in Q4 2020.

Analysis

Faeth Therapeutics (FTH) Preferred Stock Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Faeth Therapeutics 119.02 Mn -316.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 72.34 Mn
API Access

Faeth Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=FTH&period=max&api_key=YOUR_API_KEY